Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized Parallel-Group Multicenter Trial, Designed to Compare 5 Years of Adjuvant Exemestane Versus 5 Years of Observation in Postmenopausal Women With Operable Breast Cancer Who Have Received 5-7 Years of Adjuvant Tamoxifen.

NCT00810706 is registered in ClinicalTrials.gov with Hellenic Breast Surgeons Society as lead sponsor.

NCT NCT00810706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00810706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized Parallel-Group Multicenter Trial, Designed to Compare 5 Years of Adjuvant Exemestane Versus 5 Years of Observation in Postmenopausal Women With Operable Breast Cancer Who Have Received 5-7 Years of Adjuvant Tamoxifen.
Lead sponsor
Hellenic Breast Surgeons Society
Phase
Phase 3
Overall status
Terminated
Start date
April 30, 2001
Completion date
November 30, 2005
Enrollment
448 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer